OncoCyte Corporation

NASDAQ: OCX · Real-Time Price · USD
3.20
0.47 (17.22%)
At close: Jun 17, 2025, 3:59 PM

OncoCyte Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
8.64M 9.43M 19.99M 35.6M
Short-Term Investments
n/a n/a 433K 904K
Long-Term Investments
n/a n/a 1.7M 1.7M
Other Long-Term Assets
5.96M 2.16M 2.07M 1.96M
Receivables
1.61M 484K 2.01M 1.44M
Inventory
410K n/a 2.12M 304K
Other Current Assets
1.1M 782K 3.1M 2.95M
Total Current Assets
11.76M 10.7M 25.54M 39.14M
Property-Plant & Equipment
2.76M 5.44M 10.85M 8.53M
Goodwill & Intangibles
14.61M 56.59M 61.63M 109.93M
Total Long-Term Assets
23.32M 64.19M 74.56M 120.42M
Total Assets
35.08M 74.89M 100.09M 159.56M
Account Payables
2.28M 953K 1.25M 1.81M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
1.29M n/a 815K 2.13M
Other Current Liabilities
2.17M 4.01M 7.45M 6.53M
Total Current Liabilities
7.28M 7.19M 12.11M 14.12M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
37.71M 39.9M 50.96M 76.68M
Total Long-Term Liabilities
40.08M 42.1M 53.69M 80.23M
Total Liabilities
47.35M 49.3M 65.8M 94.35M
Total Debt
3.66M 2.87M 3.54M 5.68M
Common Stock
338.24M 310.3M 294.93M 252.95M
Retained Earnings
-350.54M -289.88M -260.68M -187.77M
Comprehensive Income
21K 49K 39K 37K
Shareholders Equity
-12.27M 25.59M 34.29M 65.22M
Total Investments
n/a 1.7M 433K 904K